Sign in Subscribe
Class action lawsuits

Hims & Hers Health, Inc. Class Action Lawsuit Update: Deadline to File Lead Plaintiff Motion on August 25, 2025

Strategic Insights

— 1 min read

Investors who purchased Hims & Hers Health, Inc. securities between April 29, 2025, and June 23, 2025, are reminded of the upcoming deadline to file a lead plaintiff motion in the class action lawsuit. The lawsuit alleges that Hims made materially false and/or misleading statements about its business, operations, and prospects, including the deceptive promotion and selling of knockoff versions of Wegovy. As a result, the company's share price fell significantly on June 23, 2025.

Key Takeaways:

  • The class action lawsuit was filed on behalf of investors who purchased Hims & Hers Health, Inc. securities between April 29, 2025, and June 23, 2025.
  • The lawsuit alleges that Hims made false and/or misleading statements about its business, operations, and prospects, including the deceptive promotion and selling of knockoff versions of Wegovy.
  • Novo Nordisk terminated its partnership with Hims due to the company's failure to adhere to the law and its promotion of illegitimate, knockoff versions of Wegovy.
  • The lawsuit alleges that as a result of the false and/or misleading statements, the company's share price fell $22.24, or 34.6%, to close at $41.98 per share on June 23, 2025.
  • Investors who purchased Hims securities during the Class Period may move the Court to request appointment as lead plaintiff in this putative class action lawsuit by August 25, 2025.
  • Hims & Hers Health, Inc. (NYSE: HIMX) securities were sold at a bundled offering of Novo Nordisk's FDA-approved Wegovy on the Hims & Hers platform.
  • Novo Nordisk issued a press release accusing Hims of deceptive promotion and selling of illegitimate, knockoff versions of Wegovy.
  • Hims failed to disclose to investors that the Company's collaboration with Novo Nordisk would be terminated due to their failure to adhere to the law.

Statistics:

  • Hims' share price fell $22.24, or 34.6%, to close at $41.98 per share on June 23, 2025.
  • The lawsuit alleges that Hims' share price fell due to false and/or misleading statements about its business, operations, and prospects.
  • The Class Period ran from April 29, 2025, to June 23, 2025, inclusive.

Sources:

  • Glancy Prongay & Murray LLP, 1925 Century Park East, Suite 2100, Los Angeles California 90067
  • Email: [charles.linehan@glancylaw.com](mailto:charles.linehan@glancylaw.com)
  • Telephone: 310-201-9150, Toll-Free: 888-773-9224
  • Visit our website at: [www.glancylaw.com](http://www.glancylaw.com)

Read more